Matt Hewitt
Stock Analyst at Craig-Hallum
(4.40)
# 1,255
Out of 5,085 analysts
727
Total ratings
46.8%
Success rate
8%
Average return
Main Sectors:
Stocks Rated by Matt Hewitt
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QTI QT Imaging Holdings | Initiated Coverage: Buy | $8 | $2.28 | +250.88% | 1 | Oct 5, 2026 | |
| BHST BioHarvest Sciences | Reiterated: Buy | n/a | $1.76 | - | 20 | Sep 29, 2026 | |
| LFCR Lifecore Biomedical | Downgraded: Hold | $6.28 | $6.51 | -3.53% | 40 | Sep 29, 2026 | |
| OABI OmniAb | Reiterated: Buy | n/a | $5.28 | - | 32 | Sep 29, 2026 | |
| RGEN Repligen | Reiterated: Buy | n/a | $184.69 | - | 58 | Sep 25, 2026 | |
| INFU InfuSystem Holdings | Reiterated: Buy | n/a | $14.32 | - | 21 | Sep 24, 2026 | |
| LGND Ligand Pharmaceuticals | Rated: Buy | n/a | $318.78 | - | 72 | Sep 24, 2026 | |
| PARK Park Dental Partners | Reiterated: Buy | n/a | $20.64 | - | 9 | Sep 24, 2026 | |
| CDXS Codexis | Reiterated: Buy | n/a | $1.26 | - | 53 | Sep 22, 2026 | |
| TKNO Alpha Teknova | Reiterated: Buy | n/a | $7.86 | - | 22 | Sep 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.50 | - | 32 | Sep 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $35.95 | - | 49 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.3941 | +914.97% | 14 | Aug 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $18.64 | +7.30% | 9 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $11.48 | - | 18 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $30.87 | - | 52 | Jul 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.71 | - | 36 | Jul 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $4.22 | - | 2 | Jun 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $2.61 | +129.89% | 55 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $40 | $33.73 | +18.59% | 30 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.219 | - | 1 | Mar 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $78.53 | - | 1 | Feb 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $4.92 | +143.90% | 20 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $2.34 | - | 1 | Dec 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.79 | n/a | 12 | Oct 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $27.03 | n/a | 1 | Jun 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $17.99 | n/a | 13 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $42.86 | n/a | 1 | Mar 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $0.5777 | n/a | 2 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $0.874 | n/a | 15 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $6 | $2.82 | n/a | 1 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.04 | n/a | 1 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $6.88 | n/a | 22 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $16 → $17 | $12.13 | n/a | 2 | Oct 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $100 | $0.0002 | n/a | 1 | Jan 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $215 → $154 | $72.69 | n/a | 3 | Oct 31, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 | $3.95 | n/a | 4 | Feb 27, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $50 | $118.32 | n/a | 1 | Nov 8, 2017 |
QT Imaging Holdings
Oct 5, 2026
Initiated Coverage: Buy
Price Target: $8
Current: $2.28
Upside: +250.88%
BioHarvest Sciences
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.76
Upside: -
Lifecore Biomedical
Sep 29, 2026
Downgraded: Hold
Price Target: $6.28
Current: $6.51
Upside: -3.53%
OmniAb
Sep 29, 2026
Reiterated: Buy
Price Target: n/a
Current: $5.28
Upside: -
Repligen
Sep 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $184.69
Upside: -
InfuSystem Holdings
Sep 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $14.32
Upside: -
Ligand Pharmaceuticals
Sep 24, 2026
Rated: Buy
Price Target: n/a
Current: $318.78
Upside: -
Park Dental Partners
Sep 24, 2026
Reiterated: Buy
Price Target: n/a
Current: $20.64
Upside: -
Codexis
Sep 22, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.26
Upside: -
Alpha Teknova
Sep 17, 2026
Reiterated: Buy
Price Target: n/a
Current: $7.86
Upside: -
Sep 15, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.50
Upside: -
Sep 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $35.95
Upside: -
Aug 13, 2026
Reiterated: Buy
Price Target: $4
Current: $0.3941
Upside: +914.97%
Aug 7, 2026
Reiterated: Buy
Price Target: $20
Current: $18.64
Upside: +7.30%
Aug 4, 2026
Reiterated: Hold
Price Target: n/a
Current: $11.48
Upside: -
Jul 8, 2026
Reiterated: Buy
Price Target: n/a
Current: $30.87
Upside: -
Jul 2, 2026
Reiterated: Buy
Price Target: n/a
Current: $1.71
Upside: -
Jun 2, 2026
Reiterated: Hold
Price Target: n/a
Current: $4.22
Upside: -
May 8, 2026
Reiterated: Buy
Price Target: $6
Current: $2.61
Upside: +129.89%
May 6, 2026
Reiterated: Buy
Price Target: $40
Current: $33.73
Upside: +18.59%
Mar 25, 2026
Reiterated: Buy
Price Target: n/a
Current: $0.219
Upside: -
Feb 23, 2026
Reiterated: Buy
Price Target: n/a
Current: $78.53
Upside: -
Dec 16, 2025
Reiterated: Buy
Price Target: $12
Current: $4.92
Upside: +143.90%
Dec 9, 2025
Reiterated: Buy
Price Target: n/a
Current: $2.34
Upside: -
Oct 10, 2025
Reiterated: Buy
Price Target: n/a
Current: $4.79
Upside: n/a
Jun 17, 2025
Rated: Hold
Price Target: n/a
Current: $27.03
Upside: n/a
Apr 25, 2025
Reiterated: Buy
Price Target: n/a
Current: $17.99
Upside: n/a
Mar 18, 2025
Reiterated: Buy
Price Target: n/a
Current: $42.86
Upside: n/a
Dec 18, 2024
Rated: Buy
Price Target: n/a
Current: $0.5777
Upside: n/a
Aug 7, 2024
Reiterated: Buy
Price Target: n/a
Current: $0.874
Upside: n/a
Feb 9, 2024
Rated: Buy
Price Target: $6
Current: $2.82
Upside: n/a
Sep 21, 2023
Reiterated: Buy
Price Target: n/a
Current: $8.04
Upside: n/a
Feb 23, 2023
Rated: Hold
Price Target: n/a
Current: $6.88
Upside: n/a
Oct 4, 2019
Reiterated: Hold
Price Target: $16 → $17
Current: $12.13
Upside: n/a
Jan 18, 2019
Reiterated: Hold
Price Target: $100
Current: $0.0002
Upside: n/a
Oct 31, 2018
Downgraded: Hold
Price Target: $215 → $154
Current: $72.69
Upside: n/a
Feb 27, 2018
Reiterated: Buy
Price Target: $19
Current: $3.95
Upside: n/a
Nov 8, 2017
Reiterated: Hold
Price Target: $50
Current: $118.32
Upside: n/a